Literature DB >> 16840334

Evidence of a potential receptor-binding site on the Nipah virus G protein (NiV-G): identification of globular head residues with a role in fusion promotion and their localization on an NiV-G structural model.

Vanessa Guillaume1, Hamide Aslan, Michelle Ainouze, Mathilde Guerbois, T Fabian Wild, Robin Buckland, Johannes P M Langedijk.   

Abstract

As a preliminary to the localization of the receptor-binding site(s) on the Nipah virus (NiV) glycoprotein (NiV-G), we have undertaken the identification of NiV-G residues that play a role in fusion promotion. To achieve this, we have used two strategies. First, as NiV and Hendra virus (HeV) share a common receptor and their cellular tropism is similar, we hypothesized that residues functioning in receptor attachment could be conserved between their respective G proteins. Our initial strategy was to target charged residues (which can be expected to be at the surface of the protein) conserved between the NiV-G and HeV-G globular heads. Second, we generated NiV variants that escaped neutralization by anti-NiV-G monoclonal antibodies (MAbs) that neutralize NiV both in vitro and in vivo, likely by blocking receptor attachment. The sequencing of such "escape mutants" identified NiV-G residues present in the epitopes to which the neutralizing MAbs are directed. Residues identified via these two strategies whose mutation had an effect on fusion promotion were localized on a new structural model for the NiV-G protein. Our results suggest that seven NiV-G residues, including one (E533) that was identified using both strategies, form a contiguous site on the top of the globular head that is implicated in ephrinB2 binding. This site commences near the shallow depression in the center of the top surface of the globular head and extends to the rim of the barrel-like structure on the top loops of beta-sheet 5. The topology of this site is strikingly similar to that proposed to form the SLAM receptor site on another paramyxovirus attachment protein, that of the measles virus hemagglutinin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840334      PMCID: PMC1563693          DOI: 10.1128/JVI.00190-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase.

Authors:  S Crennell; T Takimoto; A Portner; G Taylor
Journal:  Nat Struct Biol       Date:  2000-11

2.  Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Authors:  Zhongyu Zhu; Antony S Dimitrov; Katharine N Bossart; Gary Crameri; Kimberly A Bishop; Vidita Choudhry; Bruce A Mungall; Yan-Ru Feng; Anil Choudhary; Mei-Yun Zhang; Yang Feng; Lin-Fa Wang; Xiaodong Xiao; Bryan T Eaton; Christopher C Broder; Dimiter S Dimitrov
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Antibody prophylaxis and therapy against Nipah virus infection in hamsters.

Authors:  V Guillaume; H Contamin; P Loth; I Grosjean; M C Georges Courbot; V Deubel; R Buckland; T F Wild
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Nipah virus: a recently emergent deadly paramyxovirus.

Authors:  K B Chua; W J Bellini; P A Rota; B H Harcourt; A Tamin; S K Lam; T G Ksiazek; P E Rollin; S R Zaki; W Shieh; C S Goldsmith; D J Gubler; J T Roehrig; B Eaton; A R Gould; J Olson; H Field; P Daniels; A E Ling; C J Peters; L J Anderson; B W Mahy
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

5.  Location of, immunogenicity of and relationships between neutralization epitopes on the attachment protein (G) of Hendra virus.

Authors:  John R White; Victoria Boyd; Gary S Crameri; Christine J Duch; Ryan K van Laar; Lin-Fa Wang; Bryan T Eaton
Journal:  J Gen Virol       Date:  2005-10       Impact factor: 3.891

6.  EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus.

Authors:  Oscar A Negrete; Ernest L Levroney; Hector C Aguilar; Andrea Bertolotti-Ciarlet; Ronen Nazarian; Sara Tajyar; Benhur Lee
Journal:  Nature       Date:  2005-07-06       Impact factor: 49.962

7.  Rescue and propagation of fully retargeted oncolytic measles viruses.

Authors:  Takafumi Nakamura; Kah-Whye Peng; Mary Harvey; Suzanne Greiner; Ian A J Lorimer; Charles D James; Stephen J Russell
Journal:  Nat Biotechnol       Date:  2005-01-30       Impact factor: 54.908

8.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.

Authors:  Ping Yuan; Thomas B Thompson; Beth A Wurzburg; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Structure       Date:  2005-05       Impact factor: 5.006

9.  Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity.

Authors:  R M Iorio; G M Field; J M Sauvron; A M Mirza; R Deng; P J Mahon; J P Langedijk
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

10.  Nipah virus encephalitis reemergence, Bangladesh.

Authors:  Vincent P Hsu; Mohammed Jahangir Hossain; Umesh D Parashar; Mohammed Monsur Ali; Thomas G Ksiazek; Ivan Kuzmin; Michael Niezgoda; Charles Rupprecht; Joseph Bresee; Robert F Breiman
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more
  21 in total

1.  Paramyxoviruses: different receptors - different mechanisms of fusion.

Authors:  Ronald M Iorio; Paul J Mahon
Journal:  Trends Microbiol       Date:  2008-03-17       Impact factor: 17.079

2.  Stimulation of Nipah Fusion: Small Intradomain Changes Trigger Extensive Interdomain Rearrangements.

Authors:  Priyanka Dutta; Ahnaf Siddiqui; Mohsen Botlani; Sameer Varma
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

3.  Identification of Hendra virus G glycoprotein residues that are critical for receptor binding.

Authors:  Kimberly A Bishop; Tzanko S Stantchev; Andrew C Hickey; Dimple Khetawat; Katharine N Bossart; Valery Krasnoperov; Parkash Gill; Yan Ru Feng; Lemin Wang; Bryan T Eaton; Lin-Fa Wang; Christopher C Broder
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

4.  Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.

Authors:  Birgit G Bradel-Tretheway; Qian Liu; Jacquelyn A Stone; Samantha McInally; Hector C Aguilar
Journal:  J Virol       Date:  2015-05-06       Impact factor: 5.103

5.  Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein.

Authors:  Irina V Alymova; Allen Portner; Vasiliy P Mishin; Jonathan A McCullers; Pamela Freiden; Garry L Taylor
Journal:  Glycobiology       Date:  2011-08-16       Impact factor: 4.313

Review 6.  Ephrin-B2 and ephrin-B3 as functional henipavirus receptors.

Authors:  Kai Xu; Christopher C Broder; Dimitar B Nikolov
Journal:  Semin Cell Dev Biol       Date:  2011-12-30       Impact factor: 7.727

Review 7.  Henipavirus receptor usage and tropism.

Authors:  Olivier Pernet; Yao E Wang; Benhur Lee
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

8.  N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Authors:  Vasiliy P Mishin; Makiko Watanabe; Garry Taylor; John Devincenzo; Michael Bose; Allen Portner; Irina V Alymova
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

9.  Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding.

Authors:  Kimberly A Bishop; Andrew C Hickey; Dimple Khetawat; Jared R Patch; Katharine N Bossart; Zhongyu Zhu; Lin-Fa Wang; Dimiter S Dimitrov; Christopher C Broder
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

10.  Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.

Authors:  Oscar A Negrete; David Chu; Hector C Aguilar; Benhur Lee
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.